Acadia Healthcare Says It Faces New Federal Investigations
Posted inFederal-State Relations (US) Health and Human Services Department Health Insurance and Managed Care Hospitals Inspectors General Justice Department Psychiatry and Psychiatrists Securities and Commodities Violations Stocks and Bonds your-feed-healthcare

Acadia Healthcare Says It Faces New Federal Investigations

Shares of the company, one of the largest chains of for-profit psychiatric hospitals, were down 25 percent at one point.
F.D.A. Approves a New Antipsychotic Drug
Posted inBristol Myers Squibb Company Clinical Trials Dopamine Drugs (Pharmaceuticals) Food and Drug Administration Karuna Therapeutics Inc Psychiatry and Psychiatrists Psychology and Psychologists Regulation and Deregulation of Industry Research Schizophrenia Therapy and Rehabilitation Weight

F.D.A. Approves a New Antipsychotic Drug

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.